PTT Exploration and Production Public Company Limited Awarded at the Asia Responsible Enterprise Awards 2021 for ‘Community Health Development’ under Health Promotion Category
SINGAPORE, Sept. 24, 2021 /PRNewswire/ -- Enterprise Asia, the organiser of the tenth Asia Responsible Enterprise Awards (AREA) 2021, is pleased to recognise 69 outstanding award recipients and who exemplified determination and perseverance despite the trying times. PTT Exploration and Production Public Company Limited awarded in the Health Promotion Category at Asia Responsible Enterprise Awards 2021 ...
New Drug Application for Cadonilimab (PD-1/CTLA-4 Bi-Specific Antibody) for the Treatment of Relapsed or Metastatic Cervical Cancer Accepted by NMPA
HONG KONG, Sept. 24, 2021 /PRNewswire/ -- Akeso, Inc. (the Company, 9926.HK) announces that the National Medical Products Administration (the NMPA) of China has officially accepted the new drug application for the world's first-in-class Cadonilimab (PD-1/CTLA-4 bi-specific antibody, research and development code: AK104) for the treatment of relapsed or metastatic cervical cancer, which has received priority review. Cadonilimab,...
Johnson & Johnson Innovation Announces Awardees of the Digital Technologies of Tomorrow QuickFire Challenge
Awardees HelpWear and Us2.ai recognized for their novel ideas to harness the Internet of Things (IoT) and Artificial Intelligence (AI) with the aim to transform Atrial fibrillation (AFIB) patient care. SHANGHAI, Sept. 24, 2021 /PRNewswire/ -- Johnson & Johnson Innovation LLC together with Johnson & Johnson Medical Shanghai Ltd. today at AmCham China's Technology and Innovation Summit...
Results from Novavax NanoFlu Influenza Vaccine Phase 3 Clinical Trial Published in The Lancet Infectious Diseases
- Pivotal Phase 3 trial achieved all primary endpoints, demonstrating non-inferiority to a leading U.S.-licensed quadrivalent influenza vaccine - NanoFlu™ vaccine candidate induced significantly enhanced cell-mediated immune responses - NanoFlu was well-tolerated with a comparable safety profile GAITHERSBURG, Md., Sept. 24, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated...
Innovent Announces First Patient Dosed in a Phase 2 Clinical Trial of IBI112 (IL-23 Monoclonal Antibody) in Patients with Moderate-to-severe Plaque Psoriasis
SAN FRANCISCO and SUZHOU, China, Sept. 24, 2021 /PRNewswire/ -- Innovent Biologics, Group. ("Innovent") (HKEX: 01801), a world-class biopharmaceutical company that develops, manufactures and commercializes high quality medicines for the treatment of cancer, metabolic, autoimmune and other major diseases, today announced that the first patient with moderate-to-severe plaque psoriasis has been successfully dosed in a Phase 2 clinical trial...
Strategic Investment in proteanTecs from Industry Leaders MediaTek and Advantest Joined by Porsche Automobil Holding SE to Advance Electronics Health Monitoring
HAIFA, Israel, Sept. 24, 2021 /PRNewswire/ -- proteanTecs, a global leader in deep data solutions for advanced electronics, announced today a $50 million extension to their Growth Equity Round, demonstrating accelerated market adoption of system health and performance monitoring across multiple verticals. The round extension was led by Koch Disruptive Technologies (KDT)...
EZZ moves closer to breakthrough with world-first study into anti-aging product, NMN
SYDNEY, Sept. 24, 2021 /PRNewswire/ -- Australian health and wellness company, EZZ Life Science Holdings, is advancing scientific research of popular anti-aging product Nicotinamide mononucleotide (NMN), tapping into a growing trend for modern consumer products to tackle age-related wellbeing issues. EZZ is building scientific data with a leading university to show that being able to reverse age associated complications...
/C O R R E C T I O N — pHOXBIO/
In the news release, pHOXBIO Announces Breakthrough Clinical Trial Results Concluding Prophylactic Nasal Spray Prevents Infection from SARS-CoV-2, issued Sept. 22, 2021 by pHOXBIO over PR Newswire, we are advised by the company that the hyperlinks have been revised. The complete, corrected release follows: pHOXBIO Announces Breakthrough Clinical Trial Results Concluding Prophylactic...
Novavax and Serum Institute of India Announce Submission to World Health Organization for Emergency Use Listing of Novavax’ COVID-19 Vaccine
Novavax and Serum Institute of India file regulatory submission for World Health Organization Emergency Use Listing of Novavax' recombinant nanoparticle protein-based COVID-19 vaccine GAITHERSBURG, Md., Sept. 23, 2021 /PRNewswire/ -- Novavax, Inc. (Nasdaq: NVAX), a biotechnology company dedicated to developing and commercializing next-generation vaccines for serious infectious diseases, with its...
Nanoform Shortlisted For The European Small and Mid-Cap Awards 2021
HELSINKI, Sept. 23, 2021 /PRNewswire/ -- Nanoform Finland Plc ("Nanoform"), an innovative nanoparticle medicine enabling company, has made the shortlist in the `Star of Innovation' category of the 9th annual European Small and Mid-Cap Awards. The nomination is based on Nanoform being a listed company that places innovation at the centre of its strategy for business development by introducing innovative...
